UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 172

Sortiert nach

Acceptance and Commitment Therapy in Cancer: Review of Applications and Findings

Behavioral medicine (Washington, D.C.), 2019-07, Vol.45 (3), p.255-269

2019

Volltextzugriff (PDF)

Behavioral Activation and Acceptance and Commitment Therapy in the Treatment of Anxiety and Depression in Cancer Survivors: A Randomized Clinical Trial

Behavior modification, 2021-09, Vol.45 (5), p.822-859

2021

Volltextzugriff (PDF)

Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia

British journal of haematology, 2017-09, Vol.178 (5), p.764-771

2017

Volltextzugriff (PDF)

Is Activation the Active Ingredient of Transdiagnostic Therapies? A Randomized Clinical Trial of Behavioral Activation, Acceptance and Commitment Therapy, and Transdiagnostic Cognitive-Behavioral Therapy for Emotional Disorders

Behavior modification, 2023-01, Vol.47 (1), p.3-45

2023

Volltextzugriff (PDF)

ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC)

Cancers, 2021-06, Vol.13 (12), p.2869

2021

Volltextzugriff (PDF)

JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events

American journal of hematology, 2014-05, Vol.89 (5), p.517-523

2014

Volltextzugriff (PDF)

Activation vs. Experiential Avoidance as a Transdiagnostic Condition of Emotional Distress: An Empirical Study

Frontiers in psychology, 2018-09, Vol.9, p.1618

2018

Volltextzugriff (PDF)

Effects of Behavioral Activation on the Quality of Life and Emotional State of Lung Cancer and Breast Cancer Patients During Chemotherapy Treatment

Behavior modification, 2019-03, Vol.43 (2), p.151-180

2019

Volltextzugriff (PDF)

Dynamics of JAK2 V617F allele burden of CD34+ haematopoietic progenitor cells in patients treated with ruxolitinib

British journal of haematology, 2016-02, Vol.172 (4), p.639-642

2016

Volltextzugriff (PDF)

Acceptance and Commitment Therapy in group format for anxiety and depression. A systematic review

Journal of affective disorders, 2020-02, Vol.263, p.107-120

2020

Volltextzugriff (PDF)

Psychometric validation of the Environmental Reward Observation Scale (EROS) in breast cancer survivors

Anales de psicología (Murcia, Spain), 2020-01, Vol.36 (1), p.74-83

2020

Volltextzugriff (PDF)

Characterization of CD34+ hematopoietic progenitor cells in JAK2V617F and CALR-mutated myeloproliferative neoplasms

Leukemia research, 2016-09, Vol.48, p.11-15

2016

Volltextzugriff (PDF)

Mutations in the RNA splicing machinery genes in myelofibrotic transformation of essential thrombocythaemia and polycythaemia vera

British journal of haematology, 2014-02, Vol.164 (4), p.605-607

2014

Volltextzugriff (PDF)

Relationships between sleeping habits, sedentary leisure activities and childhood overweight and obesity

Psychology, health & medicine, 2014-01, Vol.19 (6), p.667-672

2014

Volltextzugriff (PDF)

Needs and demands for psychological care in university students

Psicothema, 2019-11, Vol.31 (4), p.414-421

2019

Volltextzugriff (PDF)

Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia

Leukemia, 2022-12, Vol.36 (12), p.2922-2926

2022

Volltextzugriff (PDF)

Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells

Leukemia & lymphoma, 2016-03, Vol.57 (3), p.692-699

2016

Volltextzugriff (PDF)

Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up

Annals of hematology, 2018-03, Vol.97 (3), p.443-451

2018

Volltextzugriff (PDF)

Patients´ and Therapists´ Reports of Psychotherapy Outcomes: Similarities and Differences

Psicothema, 2023-01, Vol.35 (4), p.374-384

2023

Volltextzugriff (PDF)

Treating anxiety and depression of cancer survivors: Behavioral activation versus acceptance and commitment therapy

Psicothema, 2018, Vol.30 (1), p.14-20

2018

Volltextzugriff (PDF)

Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera

European journal of haematology, 2015-03, Vol.94 (3), p.251-257

2015

Volltextzugriff (PDF)

Emotional state and psychological flexibility in breast cancer survivors

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2017-10, Vol.30, p.75-83

2017

Volltextzugriff (PDF)

Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum

Blood advances, 2022-07, Vol.6 (13), p.3921-3931

2022

Volltextzugriff (PDF)

First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma

Blood advances, 2023-01, Vol.7 (1), p.162-166

2023

Volltextzugriff (PDF)

Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features

Blood advances, 2020-10, Vol.4 (20), p.5285-5296

2020

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(155)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Acceptance and Commitment Therapy in Cancer: Review of Applications and Findings

Behavioral Activation and Acceptance and Commitment Therapy in the Treatment of Anxiety and Depression in Cancer Survivors: A Randomized Clinical Trial

Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia

Is Activation the Active Ingredient of Transdiagnostic Therapies? A Randomized Clinical Trial of Behavioral Activation, Acceptance and Commitment Therapy, and Transdiagnostic Cognitive-Behavioral Therapy for Emotional Disorders

ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC)

JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events

Activation vs. Experiential Avoidance as a Transdiagnostic Condition of Emotional Distress: An Empirical Study

Effects of Behavioral Activation on the Quality of Life and Emotional State of Lung Cancer and Breast Cancer Patients During Chemotherapy Treatment

Dynamics of JAK2 V617F allele burden of CD34+ haematopoietic progenitor cells in patients treated with ruxolitinib

Acceptance and Commitment Therapy in group format for anxiety and depression. A systematic review

Psychometric validation of the Environmental Reward Observation Scale (EROS) in breast cancer survivors

Characterization of CD34+ hematopoietic progenitor cells in JAK2V617F and CALR-mutated myeloproliferative neoplasms

Mutations in the RNA splicing machinery genes in myelofibrotic transformation of essential thrombocythaemia and polycythaemia vera

Relationships between sleeping habits, sedentary leisure activities and childhood overweight and obesity

Needs and demands for psychological care in university students

Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia

Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells

Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up

Patients´ and Therapists´ Reports of Psychotherapy Outcomes: Similarities and Differences

Treating anxiety and depression of cancer survivors: Behavioral activation versus acceptance and commitment therapy

Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera

Emotional state and psychological flexibility in breast cancer survivors

Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum

First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma

Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features

Suchergebnisse filtern